| Literature DB >> 31420828 |
Josephine Franken1, Rebecca K Stellato2, Stefaan H A J Tytgat1, David C van der Zee1, Femke A Mauritz1, Maud Y A Lindeboom3.
Abstract
INTRODUCTION: A gastrostomy placement (GP) is an established treatment to provide enteral feeding in pediatric patients with feeding difficulties aiming to improve nutritional status and health-related quality of life (HRQoL). The aim of this study was to evaluate HRQoL in children with severe feeding difficulties who have undergone GP.Entities:
Keywords: Gastrostomy; Laparoscopic gastrostomy; Percutaneous endoscopic gastrostomy; Quality of life
Mesh:
Year: 2019 PMID: 31420828 PMCID: PMC6962119 DOI: 10.1007/s11136-019-02272-z
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
PedsQLTM on health-related quality of life; age category 13–18 years
| Could you tell us to what extent your teenager had trouble with each of these things in the last month? There are no right or wrong answers. Please ask for help if you have any questions | |
0 if it was 1 if it was 2 if it was 3 If it was 4 if it was | |
| Physical functioning (having trouble with…) | |
Walking more than 100 meters Running Doing sports or other physical exercise Heavy lifting Taking a bath or shower independently Having pain Feeling tired | |
| Emotional functioning (having trouble with…) | |
Feeling afraid or scared Feeling sad Feeling angry Having trouble sleeping Being worried about what might happen to him/her | |
| Social functioning (having trouble with…) | |
Getting along with other teenagers Other kids not wanting to be friends with her/him Begin bullied by other teenagers Not being able to do things other teenagers of his/her age can do Being able to keep up with other teenagers | |
| Functioning at school (having trouble with…) | |
Paying attention in class Forgetting things Keeping up with work in class and doing his/her homework Not being able to go to school because he/she is not feeling well Not being able to go to school because he/she had to go to the doctor or hospital |
Gastrostomy placement—specific questionnaire
| Does your child still have a gastrostomy at the moment? Yes/No | |
If not, when was it removed? If yes, does he/she have a Mickey button or a permanent catheter? If yes, is he/she fed on the stomach or on the small intestine? | |
| Did your child undergo other stomach/small intestine/large intestine operations? | |
| Date and indication for operation: … | |
| Did your child undergo endoscopical investigations of the stomach or small intestine? | |
| Date and indication for investigation: … | |
| How many times did your child undergo a change of the button or catheter? | |
| 1 × 2 × 3 × 4 × 5 × 5–10 > 10 | |
| Did your child experience any of the following complications? | |
| Leakage at the gastrostomy site: daily/weekly/monthly/yearly/< yearly | |
| Spontaneous dislocation of the gastrostomy: 1 × 2 × 3 × 4 × 5 × 5–10 > 10 | |
| Infection at the gastrostomy site: 1 × 2 × 3 × 4 × 5 × 5–10 > 10 | |
| Hypergranulation at the gastrostomy site: 1 × 2 × 3 × 4 × 5 × 5–10 > 10 | |
| Other complications: … | |
| How do you rate your satisfaction with the gastrostomy on a scale from 0–10? | |
| Can you elaborate on the feeding schedule of your child? | |
| Portions scattered during the day (with pump) | |
| Portions scattered during the day (without pump) | |
| Continuous drip feeding during the night | |
| Continuous drip feeding during 24 h | |
| Did your child use any stomach enhancing medication in the last 3–4 months, for instance, domperidon (Motilium) or erythromycin? | |
| If yes, what kind of medication? In which dosage | |
| Did your child use any antacid-inhibiting medication in the last 3–4 months, for instance, omeprazole, esomeprazole, or ranitidine? | |
| If yes, what kind of medication? In which dosage |
Fig. 1Flowchart of patient inclusion. GP gastrostomy placement, UMCU University Medical Center Utrecht
Patient characteristics
| Demographics | Responders ( | Non-responders ( |
|---|---|---|
| Male gender ( | 82 (54.7%) | 76 (50.7%) |
| Age in years at operation (median with IQR) | 2.7 (1.4–6.1) | 2.7 (1.1–7.6) |
| Elapsed time since GP in years (median with IQR) | 2.9 (1.4–4.7) | 2.0 (0.8–5.0) |
| Patient deceased | 0 (0.0%) | 26 (17.3%) |
| Gastrostomy removed | 14 (9.3%) | 20 (13.3%) |
| Indication for GP | ||
| Neurologic impaired development (n; %) | 111 (74.0%) | 106 (70.7%) |
| Cystic fibrosis | 17 (11.3%) | 12 (8.0%) |
| Cardiac disease | 4 (2.7%) | 6 (4.0%) |
| Gastrointestinal | 4 (2.7%) | 5 (3.3%) |
| Renal disease | 5 (3.3%) | 2 (1.3%) |
| Psychiatric/behavioral disease | 3 (2.0%) | 5 (3.3%) |
| Failure to thrive (undiagnosed) | 4 (2.7%) | 3 (2.0%) |
| Metabolic disorder | 2 (1.3%) | 3 (2.0%) |
| Dysmorphic facial features | 0 (0.0%) | 3 (2.0%) |
| Muscle disease | 0 (0.0%) | 2 (1.3%) |
| Lung disease | 0 (0.0%) | 2 (1.3%) |
| Esophagotracheal fistula due to foreign body | 0 (0.0%) | 1 (0.7%) |
GP gastrostomy placement, IQR interquartile range
Fig. 2HRQoL stratified according to disease category. HRQoL health-related quality of life. Bars are depicted in means with standard deviations. The dotted line represents the mean HRQoL of a healthy child population, as measured by Varni et al. (82.70 ± 15.40). Neurologic impairment 45.8 (± 18.1); Cardiac disease 50.9 (± 23.1); Cystic fibrosis 68.5 (± 15.1); Behavioral disorder 72.5 (± 21.9); FTT Failure to thrive 74.5 (± 18.5); Renal disease 75.2 (± 18.9)
Results of the multiple linear regression analysis of health-related quality of life after gastrostomy placement (n = 150)
| Predictors of health-related quality of lifea | Mean difference (95% confidence interval) | Standardized beta coefficient | |
|---|---|---|---|
| Patient characteristics | |||
| Age (years) | −1.2 (−2.3 to −0.2) | −0.23 | 0.03 |
| Gender (female) | −5.5 (−16.3 to 5.3) | 0.06 | 0.32 |
| Follow-up time (years) | −0.2 (−3.8 to 3.5) | −0.16 | 0.93 |
| Medical history | |||
| Neurologic impairment | −21.4 (−32.6 to −10.3) | −0.58 | < 0.001 |
| Cardiac disease | −19.0 (−32.1 to −5.9) | −0.20 | 0.01 |
| Previous gastrointestinal surgery | −15.2 (−28.2 to −1.7) | −0.12 | 0.30 |
| Gastroesophageal reflux | −4.3 (−13.5 to 5.0) | −0.20 | 0.37 |
| Acid exposure time (%) on 24-h pH monitoring | −0.4 (−1.5 to 0.7) | −0.08 | 0.48 |
| Gastrostomy-related factors | |||
| Jejunal feeding | −33.0 (−9.3 to −56.7) | −0.3 | 0.01 |
| Reinterventions in operating theater | −16.2 (−33.2 to 0.8) | −0.2 | 0.06 |
aNegative predictors are correlated with lower outcome in health-related quality of life